COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Friday, 10 September 2021
Moderate losses to end the week - Dynavax down 7%
Moderate sell-off with an overall average drop of 1.4% with 21 stocks falling and only 4 gaining ground.
There were no double digit losses, but Dynavax, Novavax and Alnylam all had losses of over 5%.
No comments:
Post a Comment